RD
Ray Dalio (Bridgewater Associates) disclosed new in HAEMONETICS CORP MASS
Ray Dalio (Bridgewater Associates) filed a 13F change in HAEMONETICS CORP MASS (405024100) on 2026-05-15, covering period end 2026-03-31.
Action
New
Capital
$2,726,528 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.